05/03/2024
3:07 PM | Galera Therapeutics (Filer)
| Form 8-A12B | |
05/01/2024
4:02 PM | Galera Therapeutics (Issuer)
Schneid Yair (Reporting)
| Form 4/A | |
04/16/2024
3:39 PM | ALPHA PHARMA Investments LLC (Filed by)
Galera Therapeutics (Subject)
| Form SC 13G | |
04/03/2024
7:08 AM | Altamont Pharmaceutical Holdings, LLC (Filed by)
Galera Therapeutics (Subject)
| Form SC 13G/A | |
04/01/2024
8:36 PM | Altamont Pharmaceutical Holdings, LLC (Reporting)
Galera Therapeutics (Issuer)
Pearson Mark E. (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
03/28/2024
6:30 AM | Galera Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2024
6:06 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/27/2024
6:31 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
5:57 PM | Galera Therapeutics (Subject)
Sofinnova Venture Partners IX, L.P. (Filed by)
| Form SC 13D/A | |
01/16/2024
5:11 PM | Galera Therapeutics (Issuer)
Schneid Yair (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:35 AM | Galera Therapeutics (Subject)
GSA CAPITAL PARTNERS LLP (Filed by)
| Form SC 13G | |
12/04/2023
3:32 PM | Blackstone Holdings I/II GP L.L.C. (Filed by)
Galera Therapeutics (Subject)
| Form SC 13D/A | |
11/13/2023
1:22 PM | Altamont Pharmaceutical Holdings, LLC (Reporting)
Galera Therapeutics (Issuer)
Pearson Mark E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2023
1:24 PM | Altamont Pharmaceutical Holdings, LLC (Filed by)
Galera Therapeutics (Subject)
| Form SC 13G | |
10/31/2023
6:10 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
6:24 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/22/2023
4:12 PM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
6:30 AM | Galera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
6:30 AM | Galera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
6:10 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
7:00 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2023
3:19 PM | Alleva Lawrence M (Reporting)
Galera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
3:19 PM | Galera Therapeutics (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13G/A | |
06/15/2023
3:12 PM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2023
7:51 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
6:31 AM | Galera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023
6:11 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
